Sage Journals: Discover world-class research

Open access

Research article

First published 2023

Efficacy and safety of a triple combination of atezolizumab,bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter,single-arm,retrospective study

Kang Wang, Zong-Han Liu, Hong-Ming Yu [...]

Therapeutic Advances in Gastroenterology

Free access

Review article

First published 2013-1

Immunotherapy updates in pancreatic cancer: are we there yet?

Krishna Soujanya Gunturu, Gabriela R. Rossi, Muhammad Saif Wasif

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2017-8

Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions

Aurélien Lambert, Céline Gavoille, Thierry Conroy

Therapeutic Advances in Gastroenterology

Open access

Review article

First published 2024

Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear

Davide Melisi, Simona Casalino, Silvia Pietrobono [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2026

NALIRIFOX versus liposomal irinotecan plus fluorouracil/leucovorin as the second-line chemotherapy in gemcitabine refractory pancreatic adenocarcinoma: a real-world study

Wei-Ze Wong, Nai-Jung Chiang, Kuei-Chuan Lee [...]

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2016-3

A novel schedule of erlotinib/capecitabine (7/7) as salvage therapy in previously treated advanced pancreatic adenocarcinoma: a case series

Jiezhong Chen, Kristin Kaley, Marie Carmel Garcon [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2020

A phase II study of liposomal irinotecan with 5-fluorouracil,leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial

Francesca Simionato, Camilla Zecchetto, Valeria Merz [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

S-1 plus oxaliplatin versus modified FOLFIRINOX for advanced pancreatic adenocarcinoma after gemcitabine plus nab-paclitaxel failure

Hui Tang, Zhengxia Li, Tingting You [...]

Therapeutic Advances in Medical Oncology

Search results